Navigation Links
Human Genome Sciences Announces Closing of Public Offering
Date:8/3/2009

ROCKVILLE, Md., Aug. 3 /PRNewswire-FirstCall/ -- Human Genome Sciences, Inc. (Nasdaq: HGSI) today announced the closing of its public offering of 26,697,250 newly issued shares of its common stock at a price to the public of $14.00 per share, which includes 3,482,250 shares sold upon exercise by the underwriters of their option to purchase additional shares. The net proceeds to the Company from the offering are approximately $356.7 million, after deducting the underwriting discount and estimated offering expenses.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080416/HGSLOGO )

Goldman, Sachs & Co. and Citigroup Global Markets Inc. acted as joint book-running managers for the offering and Credit Suisse Securities (USA) LLC and J.P. Morgan Securities Inc. acted as co-managers for the offering.

The shares were issued pursuant to an effective shelf registration statement. This announcement shall not constitute an offer to sell or the solicitation of an offer to buy any securities of Human Genome Sciences, Inc., nor shall there be any sale of securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Printed copies of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from Goldman, Sachs & Co., at 85 Broad Street, New York, New York 10004, Attention: Prospectus Department, Toll-Free 1-866-471-2526, or by email at '/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. New Initiative Has Shocking Effect: Thousands of Missourians with Abnormal Chromosome Structures Are Not Human
3. ExonHit Therapeutics: Allergan and ExonHits First Collaboration Compound to Begin Human Clinical Trials
4. Human Genome Sciences Announces $40 Million Milestone Payment Related to Albuferon(R) Development
5. Novocell Announces Discovery Linking Key Cancer Cell Signaling Pathways With Proliferation and Self-Renewal of Human Embryonic Stem Cells
6. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Thomas Weisel Partners Conference
7. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at BioCentury-Thomson Financial Investment Conference
8. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Bear Stearns Conference
9. Human Pheromone Sciences Enters Into Agreement to Reposition and Promote its Natural Attraction(R) Brand
10. Human Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
11. Premier Research Appoints Global Head of Human Resources

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., COLUMBIA, Md., Dec. 2 /PRNewswire-FirstCall/ ... announced today that it intends to release the re...n December 16, 2009, at approximately 4:00 p.m. Ea....m. ET Martek will conduct a conference call to di...d parties may listen to the call live via webcast ...
(Date:12/2/2009)..., MANILA, Philippines, Dec. 2 Spec...growing green energy companies on the planet. Thro...e Green Planet,s President and Recycling Specialis...siness for over 25 years, stated that Spectrum Blu...tting the stage for spectacular earnings because o...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportli...rt is available in its catalogue: ,, Neurostim...://www.reportlinker.com/p0164232/Neurostimulation-...ld neurostimulation market stands enthused by the ...t rise in age-related diseases such as, Parkinson,...
(Date:12/2/2009)... , NEW YORK, Dec. 2 Reportl...ort is available in its catalogue: ,, Carbondi..., http://www.reportlinker.com/p0164368/Carbondi...l ,, Incubators are the most critical equipme...h, and other applications for providing a controll...
Breaking Biology Technology:Martek to Announce Fourth Quarter and Fiscal Year 2009 Results 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 2Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 3Reportlinker Adds Carbondioxide Incubators - A Global Market Perspective 4
...RNewswire-FirstCall/ - Angiotech Pharmaceuticals,I... pharmaceutical and,medical device company, today ...ific Corporation "BSC" (NYSE: BSX ) has received ...xel-eluting coronary stent system in Canada.,BSC r...Directorate (TPD),the authority that regulates pha...
...ASgen, Inc. presented at the AACR,meeting in San D...,s lead,compound for ovarian cancer. FAS31 is an i...that is highly expressed in many human cancers. Nu... inhibition is cytotoxic to a,variety of human xen...icity,studies, FAS31 showed no observable toxicity...
... 18 ev3 Inc. (Nasdaq:,EVVV) will release its 2008... 2008, before regular market trading hours., The ...e same day at,7:30 a.m. CT (8:30 a.m. ET). ev3 man...sults and future outlook, followed by a question a...vailable to interested parties through a,live audi...
Other Biology Technology:Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 2Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 3Angiotech's Corporate Partner, Boston Scientific, Reports Canadian Approval for TAXUS(R) Liberte(R) Stent System 4FASgen, Inc. Presents Ovarian Cancer Efficacy and Toxicology Data to the American Association for Cancer Research 2
(Date:12/2/2009)... Children exposed to secondhand cigarette smoke ha...adulthood, even if they never smoked. , Results...gy, Biomarkers & Prevention , a journal of the Ame...a special tobacco focus in the December issue. ,...l be diagnosed with lung cancer; more than 159,000...
(Date:12/2/2009)...A Less acculturated Latino men have a more diffic...acculturated to U.S. culture, but acculturation ha...etails of these findings are published in Cancer ...of the American Association for Cancer Research. T..., "Acculturation affects smoking cessation diffe...
(Date:12/2/2009)... New study results strengthen the evidence that pe...me have an increased risk for developing colorecta...ors. , "This provides one more reason not to sm...author Michael J. Thun, M.D., M.S., vice president...at the American Cancer Society. "Colorectal cancer...
Breaking Biology News(10 mins):Secondhand smoke exposure in childhood increases lung cancer risk later in life 2Acculturation affects smoking cessation success among Latinos 2Cigarette smoking increases colorectal cancer risk 2FDLI Publishes New FDA Directory With Obama Appointees 52602 11 in 7 Low Income Preschoolers Is Obese 52597 11 in 7 Low Income Preschoolers Is Obese 52597 2Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 1Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 2Providence Service Corporation to Report Second Quarter 2009 Results on Monday August 10th After the Market Closes 52594 3
...ires in Indonesia responsible for some of the wor...t only to drought, but also to changes in land use...in Nature Geoscience led by Robert Field of the ...Indonesian Borneo changed from being highly fire-r..., marking the period when one of the world,s great...
... BIO-key International, Inc. (OTC Bulletin Board:...ication and wireless public safety solutions, anno...apital,s Homeland Security Investor Conference to ...ails regarding BIO-key,s participation at the conf...rial Capital,s Homeland Security Investor Conferen...
...ary 18 Precise Biometrics came in,first place in ...the GSMA,World Mobile Congress - the world,s large...ile aviation solution is based on Precise Match-on...rprint recognition and mobile phones. , SIMagi...ive solutions for,mobile communication and Java ca...
Other Biology News:Atmospheric scientists trace the human role in Indonesian forest fires 2BIO-key(R) Announces Conference Schedule 2Mobile Communication Market Opens up for Biometrics - Precise Biometrics Awarded 1st Prize at GSMA World Mobile Congress 2
HRP Monoclonal-Goat Diluent - 5X Concentrate from BioFX Laboratories, Inc.
Rabbit Anti-Mouse Junctophilin-4, C-Terminus Monoclonal Antibody, Unconjugated, Clone PADZMD.487 from Invitrogen
...153; PCR Cloning Kits are designed to speed up the...oducts, regardless of sequence or type of polymera...including those that are difficult to clone by oth...code for potentially detrimental proteins can be c...
Mounting Medium from BioVision
Biology Products: